Empagliflozin as add-on to metformin in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial (Q42706050)
Jump to navigation
Jump to search
scientific article published on 10 April 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Empagliflozin as add-on to metformin in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial |
scientific article published on 10 April 2014 |
Statements
1 reference
Empagliflozin as add-on to metformin in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial (English)
1 reference
Hans-Ulrich Häring
1 reference
Ludwig Merker
1 reference
Elke Seewaldt-Becker
1 reference
Marc Weimer
1 reference
Thomas Meinicke
1 reference
Uli C Broedl
1 reference
Hans J Woerle
1 reference
EMPA-REG MET Trial Investigators
1 reference
10 April 2014
1 reference
1 reference
Identifiers
1 reference